Fny Investment Advisers, LLC Gritstone Bio, Inc. Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
SELL
$4.03 - $12.19 $28,790 - $87,085
-7,144 Closed
0 $0
Q4 2021

Jan 10, 2022
BUY
$8.76 - $13.71 $62,581 - $97,944
7,144 New
7,144 $91,000
Q1 2019

Apr 17, 2019
SELL
$9.97 - $18.96 $1,994 - $3,792
-200 Closed
0 $0
Q4 2018

Jan 22, 2019
SELL
$11.61 - $31.1 $12,387 - $33,183
-1,067 Reduced 84.21%
200 $3,000
Q3 2018

Oct 29, 2018
BUY
$14.24 - $14.24 $18,042 - $18,042
1,267 New
1,267 $18,000

Others Institutions Holding GRTS

# of Institutions
61
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email